NCT05786339View on ClinicalTrials.gov

Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 17, 2018

Primary Completion Date

January 16, 2019

Study Completion Date

May 15, 2019

Conditions
Therapeutic Equivalency
Interventions
DRUG

Tested Irbesartan Tablet

T

DRUG

Reference Irbesartan Tablet

R

Trial Locations (1)

266003

Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT05786339 - Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter